Ignite Creation Date:
2024-05-05 @ 6:32 PM
Last Modification Date:
2024-10-26 @ 9:35 AM
Study NCT ID:
NCT00509665
Status:
COMPLETED
Last Update Posted:
2018-07-12
First Post:
2007-07-30
Brief Title:
Gemcitabine and Doxorubicin in Treating Patients With Recurrent or Progressive Head and Neck Cancer
Sponsor:
Medical University of South Carolina
Organization:
Medical University of South Carolina
Organization Data
Organization:
Medical University of South Carolina
Class:
OTHER
Study ID:
CDR0000558049
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Medical University of South Carolina
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None